Ensign Peak Advisors’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.01M | Buy |
+91,897
| New | +$4.01M | 0.01% | 690 |
|
|
2024
Q1 | – | Sell |
-40,207
| Closed | -$1.02M | – | 1738 |
|
|
2023
Q4 | $1.02M | Hold |
40,207
| – | – | ﹤0.01% | 1363 |
|
|
2023
Q3 | $559K | Hold |
40,207
| – | – | ﹤0.01% | 1557 |
|
|
2023
Q2 | $924K | Hold |
40,207
| – | – | ﹤0.01% | 1329 |
|
|
2023
Q1 | $1.19M | Hold |
40,207
| – | – | ﹤0.01% | 1100 |
|
|
2022
Q4 | $1M | Sell |
40,207
-7,340
| -15% | -$183K | ﹤0.01% | 1159 |
|
|
2022
Q3 | $1.04M | Buy |
47,547
+1,130
| +2% | +$24.6K | ﹤0.01% | 1050 |
|
|
2022
Q2 | $914K | Sell |
46,417
-12,863
| -22% | -$253K | ﹤0.01% | 1158 |
|
|
2022
Q1 | $2.51M | Hold |
59,280
| – | – | 0.01% | 798 |
|
|
2021
Q4 | $3.76M | Buy |
59,280
+26,540
| +81% | +$1.68M | 0.01% | 750 |
|
|
2021
Q3 | $1.92M | Sell |
32,740
-30,000
| -48% | -$1.76M | ﹤0.01% | 1153 |
|
|
2021
Q2 | $3.04M | Hold |
62,740
| – | – | 0.01% | 877 |
|
|
2021
Q1 | $2.44M | Buy |
62,740
+42,740
| +214% | +$1.66M | 0.01% | 1007 |
|
|
2020
Q4 | $1.24M | Hold |
20,000
| – | – | ﹤0.01% | 1308 |
|
|
2020
Q3 | $646K | Buy |
+20,000
| New | +$646K | ﹤0.01% | 1458 |
|